Skip to main content
Cambridge Open Access logoLink to Cambridge Open Access
. 2018 Feb;145(2):156. doi: 10.1017/S0031182017000877

The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis – Corrigendum

A Q I ALQAISI, A J MBEKEANI, M BASSAS LLORENS, A P ELHAMMER, P W DENNY
Editor: Paul W Denny
PMCID: PMC5964473  PMID: 28595661

The authors apologise for errors which appear in the legend of Figure 2. Please find below the corrected legend.

Fig. 2. ED50 of Aureobasidin A (AbA, A-D) or Compound 20 (Cpmd 20, E-H) – µg mL−1; (95% Confidence Interval) – against the Toxoplasma RH tachyzoite form in HFF cells. 6 days post addition of the compounds. In agreement with Sonda et al. (2005), both compounds were non-toxic to HHF cells under the conditions employed. A and E: no wash out post-compound addition; B and F: wash out 2 h post-compound addition; C and G: wash out 8 h post-compound addition; D and H: 2 h pre-treatment of isolated parasites pre-infection. Calculated using GraphPad Prism 7, log (inhibitor) vs normalized response – Variable slope. >10 µg mL−1 – ED50 could not be determined. Representative in triplicate dataset.

REFERENCE

  1. Alqaisi A. Q. I., Mbekeani A. J., Bassas Llorens M., Elhammer A. P. and Denny P. W. (2017). The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis Parasitology. Published by Cambridge University Press, 10 May 2017. doi: 10.1017/S0031182017000506. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Parasitology are provided here courtesy of Cambridge University Press

RESOURCES